期刊文献+

补体C3a/C3aR与肾脏疾病 被引量:3

下载PDF
导出
摘要 补体系统(Complement system)是由补体及其调节因子和相关膜蛋白组成的机体免疫反应系统.补体可由经典激活途径、凝集素激活途径及旁路激活途径(替代激活途径)三条途径被激活,从而产生溶细胞、清除免疫复合物、介导炎症[1]等效应.C3是补体固有成分之一,同时也是人体正常血清中含量最多的补体成分.
出处 《中国中西医结合肾病杂志》 2013年第12期1111-1113,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 四川省科技厅科技支撑项目(No.2011SZ0215 2012SZ0027)
  • 相关文献

参考文献8

二级参考文献110

  • 1吴义超,刘志红,曾彩虹,苏健,陈朝红,黎磊石.糖尿病肾病患者肾小球基因表达谱及其与病情进展的关系[J].肾脏病与透析肾移植杂志,2004,13(6):503-511. 被引量:14
  • 2陈建康,邹万忠,由江峰.内皮素与肾小球系膜细胞的关系[J].中华病理学杂志,1996,25(4):206-208. 被引量:26
  • 3陈姗,刘志红,王瑞石,孙骅,陈丹,陈朝红,黎磊石.糖尿病肾病疾病进展相关基因的基因组学研究[J].中华肾脏病杂志,2006,22(9):528-534. 被引量:13
  • 4Muller GA, Zeisberg M, Strutz F. The importance of tubulointerstitial damage in progressive renal diseases. Nephrol Dial Transplant,2000,15 Suppl 6:~76-77.
  • 5Ichida S,Yuzawa Y,Okada H, et al. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int,2002,46 : 89-95.
  • 6Giuseppe C,Valentina C,Nicoletta F, et al. CD40 Ligand Increases Complement C3 Secretion by Proximal Tubular Epithelial Cells. J Am Soc Nephrol, 2005,16 : 2003-2011.
  • 7Tang S,Lai KN,Chan TM, et al. Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. Am J Kidney Dis,2001,37: 94- 103.
  • 8Clark EC,Nath KA,Hostetter MK, et al. Role of ammonia in progressive interstitial nephritis. Am J Kidney Dis, 1991,17 (5 Suppl 1): 15-19.
  • 9Lan HY. Tubular epithelial - myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens, 2003,12 : 25-29.
  • 10Lin ZH, Fukuda N,Jin XQ, et al. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension, 2004,44 : 25-26.

共引文献56

同被引文献77

  • 1张雅妮,陈政良.补体系统与树突状细胞的相互关系[J].现代免疫学,2008,28(1):71-74. 被引量:4
  • 2Wild S, Roglic G, Green A, et al. Global prevalence of diabetes : estimates for the year 2000 and projections for 2030. Diabetes Care,2004,27(5 ) : 1047 - 1053.
  • 3Boddana P,Caskey F,Casula A,et al. UK Renal Registry llth Annual Report ( December 2008 ) : Chapter 14 UK Renal Registry and international comparisons. Nephron Clin Pract, 2009, 111 ( Suppll ) : c269 - c76.
  • 4Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2004 annual data report : atlas of end - stage renal disease in the United States. Am J Kidney Dis ,2005, 45(1 Suppl 1) :A5 -A7,S1 - S280.
  • 5Maric C. Vasoactive hormones and the diabetic kidney. Scientific World Journal,2008,8:470 - 485.
  • 6Rosoklija GB, Dwork HJ, Younger Ds, et al. Local activation of the complement system in endoneurial microvessels of diabetic nephmpathy. Acta Neuropathologica,2000,99 ( 1 ) : 55 - 62.
  • 7Zhang J, Gerhardinger C, Lorenzi M. Early complement activition and decreased levels of glycosylphosphatidylinOsitol - an choued complement inhibitors in human and experimental diabetic reti- nopathy. Diabetes,2002,51 (12) :3499.
  • 8Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classifica- tion of diabetic nephropathy. J Am Soc Nephrol,2010,21 (4) : 556 - 563.
  • 9Collard CD, Lekow ski R, Jordan JE, et al. Complement activation following oxidative stress. Molecular Immunology, 1999,36 ( 13 - 14) :941 -948.
  • 10Ali H. Regulation of human mast cell and basophil function by anaphytatoxins C3 a and C5 a. Immunol Lett ,2010 ,128 ( 1 ) :36 - 45.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部